
About Genotypic Technology Private Limited
Data last updated:
Genotypic Technology Private Limited is a private limited company based in Bangalore, Karnataka, India. It operates in the biotechnology segment of the life sciences sector. It was incorporated on 09 October 1998 and has been in existence for over 28 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72200KA1998PTC049038. Its GSTIN is 29AABCG2490G1ZL (Karnataka).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹25.78 Lakh. It is led by directors Raja Chinnadurai Mugasimangalam (Managing Director) and Sudha Narayan Rao (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at No. 259 Apurva 2nd Floor 4th Cross 80 Feet Road R. M. V. 2nd Stage, Bangalore, Karnataka, India – 560094.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.04 Cr, a decline of 25% compared to the previous year. For the same year it recorded a net profit of ₹60.21 Lakh (net margin 1.5%) and EBITDA of ₹2.39 Cr (EBITDA margin 6.1%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 22% over five years.
The company has about 82 employees on its provident fund (EPFO) records. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand: Genotypic. As per MCA filings, the company has open charges of ₹7.5 Cr and satisfied charges of ₹1.77 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website genotypic.co.in.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressNo. 259 Apurva 2nd Floor 4th Cross 80 Feet Road R. M. V. 2nd Stage, Bangalore, Karnataka, India – 560094
- IndustryLife Sciences, Biotechnology
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Genotypic Technology Private Limited
The main business activity of Genotypic Technology is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Genotypic Technology Private Limited FY 2024 filings available
Genotypic Technology Private Limited reported revenue of ₹39.04 Cr (down 25% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Genotypic Technology Private Limited
Revenue fell 25% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 22%. EBITDA fell 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Genotypic Technology Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.39 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹60.21 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Genotypic Technology Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Genotypic Technology are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Genotypic Technology Private Limited
Genotypic Technology Private Limited is compared with the companies closest to it by revenue in the Biotechnology industry (Biotechnology). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ongc Teri Biotech Limited | ₹43.18 Cr (FY 2025) | •••• | •••• | -3.0% | •••• | New Delhi, Delhi, India |
| Symbiotic Sciences Private Limited | ₹43.02 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | New Delhi, Delhi, India |
| Techinvention Lifecare Limited | ₹40.24 Cr (FY 2025) | •••• | •••• | 20.0% | •••• | Mumbai, Maharashtra, India |
| QBD Biosciences Private Limited | ₹40.23 Cr (FY 2023) | •••• | •••• | 105.0% | •••• | Rohtak, Haryana, India |
| QB Biotechnology Private Limited | ₹39.42 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Mumbai, Maharashtra, India |
| Genotypic Technology Private Limited this company | ₹39.04 Cr (FY 2025) | •••• | •••• | -25.0% | •••• | Bangalore, Karnataka, India |
| Uvj Technologies Private Limited | ₹38.73 Cr (FY 2025) | •••• | •••• | -7.0% | •••• | Kochi, Kerala, India |
| Bills Biotech Private Limited. | ₹38.67 Cr (FY 2025) | •••• | •••• | 202.0% | •••• | Ahmedabad, Gujarat, India |
| Genex India Bioscience Private Limited | ₹38.64 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Chennai, Tamil Nadu, India |
| Tripura Bio-Tech Limited | ₹37.72 Cr (FY 2023) | •••• | •••• | 94.0% | •••• | Yadadri Bhongir, Telangana, India |
| Divi's Biotech Private Limited | ₹37.64 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
Peers are the five companies nearest above and the five nearest below Genotypic Technology by revenue in the Biotechnology industry (Biotechnology), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Genotypic Technology Private Limited
Genotypic Technology Private Limited is audited by RAJAN SANKAR AND CO for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| RAJAN SANKAR AND CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Genotypic Technology Private Limited
Genotypic Technology has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Raja Chinnadurai Mugasimangalam | Managing Director | 09 Oct 1998 | 28 Years 0 Months | Current |
| Sudha Narayan Rao | Whole-Time Director | 29 Sep 1999 | 27 Years 0 Months | Current |
Ownership and Shareholding of Genotypic Technology Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Genotypic Technology Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Mar 2022 | Hdfc Bank Limited | ₹14.05 Lakh | Open |
| 14 Dec 2012 | Canara Bank | ₹11.33 Lakh | Open |
| 19 Jul 2008 | Canara Bank | ₹7.25 Cr | Open |
| 30 May 2014 | Siemens Financial Services Private Limited | ₹1.4 Cr | Satisfied |
| 30 Mar 2009 | Canara Bank | ₹2.85 Lakh | Satisfied |
Total charge records: 6 View all charges
Associated Brands with Genotypic Technology Private Limited
Genotypic Technology operates one associated brand: Genotypic. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Provider of genomics and bioinformatics services | genotypic.co.in |
Employees and EPFO Compliance at Genotypic Technology Private Limited
Genotypic Technology Private Limited has a workforce of 82 employees as of Apr 06, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Group Structure of Genotypic Technology Private Limited
Genotypic Technology has 2 subsidiary companies. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares Held |
|---|---|---|
| Qtlomics Technologies Private Limited | U01400KA2013PTC071008 | Locked |
| Dhiti Omics Technologies Private Limited | U24100KA2014PTC075038 | Locked |
Showing major subsidiaries. Total: 2.
CIN History of Genotypic Technology Private Limited
Genotypic Technology has one previous CIN (Corporate Identification Number): U72200TZ1998PTC008603. The current CIN is U72200KA1998PTC049038, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U72200KA1998PTC049038 | Current |
| U72200TZ1998PTC008603 | Previous |
Recent Activity on Genotypic Technology Private Limited
Genotypic Technology Private Limited has 4 board changes on record since 1998: 2 appointments and 2 cessations. The latest: Anuja Vivek Joshi ceased to be Director on 16 Mar 2020.
5 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Genotypic Technology Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Genotypic Technology Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Genotypic Technology Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Genotypic Technology Private Limited
Genotypic Technology has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AABCG2490G1ZL | Karnataka | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Genotypic Technology Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Genotypic Technology Private Limited
Genotypic Technology is an active private limited company based in Bangalore, Karnataka, India. The company works in biotechnology, within the life sciences industry. It was incorporated on 09 October 1998 (28+ years old) and is registered under CIN U72200KA1998PTC049038.
Genotypic Technology reported revenue of ₹39.04 Cr for FY 2025 (down 25% YoY).
Genotypic Technology has 2 current directors:
- Raja Chinnadurai Mugasimangalam - Managing Director
- Sudha Narayan Rao - Whole-Time Director
Genotypic Technology reported a net profit of ₹60.21 Lakh (net margin 1.5%) and EBITDA of ₹2.39 Cr (EBITDA margin 6.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Genotypic Technology is 11% over three years and 22% over five years. In the latest year (FY 2025) revenue fell 25%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Genotypic Technology is 29AABCG2490G1ZL, registered in Karnataka.
The CIN (Corporate Identification Number) of Genotypic Technology is U72200KA1998PTC049038. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Genotypic Technology was incorporated on 09 October 1998, making it 28+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Genotypic Technology by revenue are Ongc Teri Biotech Limited, Symbiotic Sciences Private Limited, Techinvention Lifecare Limited, QBD Biosciences Private Limited, QB Biotechnology Private Limited and 5 more, all in the Biotechnology industry (Biotechnology).
Anuja Vivek Joshi ceased to be Director on 16 Mar 2020. Ramesh Kannan ceased to be Director on 30 Dec 2014. Sudha Narayan Rao was appointed as Whole-Time Director on 29 Sep 1999. Genotypic Technology has 4 board changes on record in total.
Genotypic Technology can be reached through the website genotypic.co.in. Its registered office is in Bangalore, Karnataka, India.